About Wyeth

Outstanding Global Brands, Exciting New Products and a Rich Research Pipeline

Wyeth improves the lives of millions of people around the world with its outstanding products. And new, innovative medicines are on the way. With research and development (R&D) programs focused on small molecules, vaccines, and biotechnology, Wyeth is exploring more than 90 new therapies for medical conditions such as diabetes, breast cancer, multiple sclerosis, Alzheimer’s disease, and schizophrenia.

Wyeth Pharmaceuticals

Wyeth has a long history of pioneering developments in pharmaceuticals and biotechnology, with leading products in the areas of women’s health care, neuroscience, musculoskeletal disorders, vaccines and infectious disease, hemophilia, and oncology. Wyeth also is a leader in the development of nutritionals.

Women’s Health Care

For more than 65 years, Wyeth has been a leader in women’s health care with its postmenopausal hormone therapies and oral contraceptives. Wyeth continues to have active product development programs in this important category and is committed to developing new therapies with the potential to significantly improve the health of women worldwide.

Neuroscience

Wyeth’s global neuroscience efforts have produced a novel therapy for depression and for the treatment of generalized anxiety disorder. Working with three discovery platforms—small molecules, vaccines and biotechnology—Wyeth researchers continue to develop treatments targeted for a wide range of central nervous system disabilities, such as multiple sclerosis, Alzheimer’s disease, depression, anxiety and schizophrenia.

Vaccines and Infectious Disease

Wyeth’s vaccines and infectious disease franchises share a common mission: to reduce the number of serious illnesses and deaths from bacterial and viral infections and to address the growing problem of bacterial resistance to existing treatments. In recent years, Wyeth has developed some of the most innovative vaccines in the health care arena. Our R&D focuses on producing vaccines for infants, children, and adults around the world. We are proud of the impact Wyeth has had on children’s lives, and we are dedicated to continually developing vaccines so children and adults can have a healthier future.

Musculoskeletal Disorders

Wyeth’s musculoskeletal disorders franchise develops important new therapies for patients with joint and bone disease. Our products include treatments for rheumatoid arthritis that help patients lead more active lives. In addition, Wyeth has a strong presence in the osteoarthritis treatment market. In research, Wyeth scientists are investigating novel treatments for bone and tissue repair.

Internal Medicine

Our internal medicine franchise includes gastrointestinal products. Wyeth’s internal medicine researchers are exploring novel approaches to treat diabetes and gastrointestinal disorders.

Hemophilia Treatment

Since the 1980s, Wyeth has been a global leader in the search for safer and more effective treatments for hemophilia A and B. As a result of this commitment and a significant investment in recombinant DNA technology, our efforts have led to important medical advances in the treatment of these potentially debilitating diseases.

Oncology

Our efforts in oncology include chemotherapy agents for acute myeloid leukemia, renal cell cancer, and a platelet growth promoter to help patients after chemotherapy. Wyeth currently has several promising oncology therapies in clinical trials, including treatments for non-Hodgkin's lymphoma, breast cancer, and chronic myeloid leukemia.

Wyeth Consumer Healthcare

Wyeth Consumer Healthcare is built on strong global brands, including some of the world’s most trusted and best-known consumer health care products. Three of our well-established product lines—Caltrate^®, Centrum^®, and Robitussin^®—are among the top nonprescription medicines in the world. Other key brands include ChapStick^®, ThermaCare ^® heat wraps, Alavert^®, Preparation H^®, and Dimetapp^®.

Fort Dodge Animal Health

As a world leader in animal health, Fort Dodge Animal Health offers a broad range of biological and pharmaceutical products for the companion animal, equine, livestock, swine and poultry industries. Innovative Fort Dodge products include ProMeris^® , ProHeart^® 6, West Nile-Innovator^®, the Duramune^® vaccine line, CYDECTIN^® Pour-on, the Pyramid^® vaccine line, Quest^® and Quest^® Plus.

250601-01